|
Sanarus Medical
|
United States |
1 Nov 2003 |
Series C
|
|
|
|
Sanarus Medical
|
United States |
1 Feb 2007 |
Series E
|
|
|
|
SARcode Bioscience Inc
|
United States |
1 Jul 2011 |
Series B
|
|
|
|
Scynexis Inc
Provider of drug discovery, development, and manufacturing projects. |
United States |
|
N/A
|
|
|
|
Silence Therapeutics PLC
|
United Kingdom |
|
N/A
|
|
|
|
Sonexa Therapeutics Inc
|
United States |
|
N/A
|
|
|
|
Sunesis Pharmaceuticals Inc
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he |
United States |
|
N/A
|
|
|
|
SurgRx Inc
|
United States |
|
N/A
|
|
|
|
Sutro Biopharma Inc
|
United States |
|
N/A
|
|
|
|
Swedish Orphan Biovitrum AB
Swedish pharmaceutical company with a product portfolio consisting of some 60 orphan and specialty pharmaceuticals |
Sweden |
|
N/A
|
|
|
|
Synad Technologies
|
United Kingdom |
|
N/A
|
|
|
|
Syntonix Pharmaceuticals Inc
A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into |
United States |
|
N/A
|
|
|
|
Tacit Software Inc
|
United States |
|
N/A
|
|
|
|
Taligen Therapeutics Inc
|
United States |
|
N/A
|
|
|
|
Telik Inc
|
United States |
|
N/A
|
|
|
|
Terawave Communications Inc
Leading GPON Innovator. |
United States |
3 Feb 2000 |
Series B
Round participant. Active |
|
|
|
The Medicines Company
|
United States |
|
N/A
|
|
|
|
Threshold Pharmaceuticals Inc
|
United States |
|
N/A
|
|
|
|
Torrey Pines Therapeutics Inc
|
United States |
|
N/A
|
|
|
TransMedics Inc
|
United States |
13 Apr 2007 |
Series D
Round participant. Active |
|